From: Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties
Compd. no.
M.W. (g/mol)
DHFR inhibition (IC50 ± SD; µM)
8d
670
0.199 ± 0.016
Methotrexate
454.44
0.131 ± 0.007